Li-Fraumeni Syndrome: Mutation of

Li–Fraumeni syndrome (LFS) TP53 biomarker cancer predisposition germline mutation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Jul 2022
Historique:
received: 01 07 2022
revised: 23 07 2022
accepted: 26 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 13 8 2022
Statut: epublish

Résumé

Li-Fraumeni syndrome (LFS) is a rare familial tumor predisposition syndrome with autosomal dominant inheritance, involving germline mutations of the

Identifiants

pubmed: 35954327
pii: cancers14153664
doi: 10.3390/cancers14153664
pmc: PMC9367397
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Italian Association for Cancer Research
ID : 22759

Références

Oncogene. 2013 Mar 7;32(10):1252-65
pubmed: 22580601
Cancer Genet. 2020 Oct;248-249:11-17
pubmed: 32966936
EMBO Rep. 2010 Nov;11(11):822-6
pubmed: 20930848
EMBO Rep. 2016 Feb;17(2):188-201
pubmed: 26691213
Fam Cancer. 2014 Mar;13(1):127-30
pubmed: 23884452
Cancer Genet. 2019 Jun;235-236:21-27
pubmed: 31296311
Cells. 2021 Dec 02;10(12):
pubmed: 34943910
Recent Pat Anticancer Drug Discov. 2021;16(2):161-186
pubmed: 34132186
Cancer Genet. 2015 Jan-Feb;208(1-2):47-51
pubmed: 25683625
J Exp Clin Cancer Res. 2018 Feb 15;37(1):30
pubmed: 29448954
Science. 1990 Nov 30;250(4985):1233-8
pubmed: 1978757
Cancer. 2016 Dec 1;122(23):3673-3681
pubmed: 27496084
Int J Clin Oncol. 2021 Dec;26(12):2161-2178
pubmed: 34633580
Front Oncol. 2015 Nov 11;5:249
pubmed: 26618142
J Natl Cancer Inst. 2020 Oct 1;112(10):1021-1029
pubmed: 31922567
Cancer Res. 2020 Jan 15;80(2):354-360
pubmed: 31719101
Semin Cancer Biol. 2021 Oct;75:72-83
pubmed: 32927018
Cold Spring Harb Symp Quant Biol. 2015;80:139-45
pubmed: 26642854
J Clin Oncol. 2015 Jul 20;33(21):2331-3
pubmed: 26101242
Cold Spring Harb Perspect Biol. 2010 Apr;2(4):a001115
pubmed: 20452944
Cold Spring Harb Symp Quant Biol. 2016;81:37-40
pubmed: 27932563
Nat Biotechnol. 2019 Nov;37(11):1351-1360
pubmed: 31570899
Curr Opin Oncol. 2018 Jan;30(1):23-29
pubmed: 29076966
Cancer Surv. 1995;25:101-24
pubmed: 8718514
Cancer Genet. 2020 Jan;240:54-58
pubmed: 31778928
J Med Genet. 2001 Jan;38(1):43-7
pubmed: 11332399
Cell. 1979 May;17(1):43-52
pubmed: 222475
Cancer Res. 1994 Mar 1;54(5):1298-304
pubmed: 8118819
World J Urol. 2022 Jan;40(1):61-69
pubmed: 34657209
J Clin Oncol. 2014 Jul 1;32(19):2001-9
pubmed: 24733792
Cell Death Differ. 2022 May;29(5):983-987
pubmed: 35361963
Eur J Hum Genet. 2020 Oct;28(10):1379-1386
pubmed: 32457520
Cell. 2012 Jan 20;148(1-2):244-58
pubmed: 22265415
Cell Death Differ. 2018 Jan;25(1):161-168
pubmed: 29099488
Cell. 2004 Nov 24;119(5):591-602
pubmed: 15550242
Front Oncol. 2022 Mar 16;12:836937
pubmed: 35371985
JAMA Oncol. 2017 Dec 1;3(12):1634-1639
pubmed: 28772291
Hum Mutat. 2021 Mar;42(3):223-236
pubmed: 33300245
Oncogene. 2013 Sep 12;32(37):4325-30
pubmed: 23318424
Hum Mutat. 2014 Jun;35(6):654-62
pubmed: 24706533
Cell Death Dis. 2021 May 11;12(5):468
pubmed: 33976116
Clin Genet. 2019 Sep;96(3):216-225
pubmed: 31081129
J Clin Oncol. 2021 May 10;39(14):1584-1594
pubmed: 33449813
Cancer Res. 2007 Feb 15;67(4):1415-8
pubmed: 17308077
Br J Haematol. 2017 Feb;176(4):539-552
pubmed: 27984644
Nature. 1979 Mar 15;278(5701):261-3
pubmed: 218111
Cells. 2021 Nov 12;10(11):
pubmed: 34831372
Cancers (Basel). 2022 Jan 13;14(2):
pubmed: 35053544
JAMA Oncol. 2021 Dec 01;7(12):1800-1805
pubmed: 34709361
Semin Cell Dev Biol. 2020 Feb;98:105-117
pubmed: 31112799
J Natl Cancer Inst. 2018 Aug 1;110(8):863-870
pubmed: 29529297
Annu Rev Med. 2015;66:17-29
pubmed: 25386929
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
J Natl Compr Canc Netw. 2020 Apr;18(4):380-391
pubmed: 32259785
Genes Dev. 2021 Apr 1;35(7-8):433-448
pubmed: 33861719
Breast Cancer Res Treat. 2020 May;181(1):181-188
pubmed: 32246378
EMBO J. 2011 Feb 2;30(3):524-32
pubmed: 21217645
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Lancet Oncol. 2016 Sep;17(9):1295-305
pubmed: 27501770
Cancer Res. 2020 Sep 1;80(17):3732-3744
pubmed: 32675277
Cancer Med. 2020 Nov;9(21):7954-7963
pubmed: 32931654
Trends Cell Biol. 2021 Apr;31(4):298-310
pubmed: 33518400
Cold Spring Harb Perspect Med. 2016 May 02;6(5):
pubmed: 27141080
Braz J Med Biol Res. 2000 Oct;33(10):1225-34
pubmed: 11004724
Mol Cancer. 2022 Jan 28;21(1):33
pubmed: 35090471
Genes Dev. 2018 Nov 1;32(21-22):1420-1429
pubmed: 30366906
Nat Commun. 2022 May 19;13(1):2800
pubmed: 35589715
Transl Cancer Res. 2021 Jun;10(6):3090-3110
pubmed: 35116619
Mol Oncol. 2016 Aug;10(7):1008-29
pubmed: 27118659
J Clin Oncol. 2015 Jul 20;33(21):2345-52
pubmed: 26014290
Br J Cancer. 2020 Feb;122(3):405-412
pubmed: 31780779
Nat Rev Cancer. 2018 Feb;18(2):89-102
pubmed: 29242642
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1220-9
pubmed: 25733866
Adv Cancer Res. 2000;77:81-137
pubmed: 10549356
J Clin Invest. 2017 Jan 3;127(1):132-136
pubmed: 27869650
Nat Cell Biol. 2018 Jan;20(1):28-35
pubmed: 29255172
Biochem Soc Trans. 2016 Apr 15;44(2):460-6
pubmed: 27068955
Front Cell Dev Biol. 2021 Dec 06;9:695723
pubmed: 34957087
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11264-9
pubmed: 18685109
EMBO Mol Med. 2021 Feb 5;13(2):e10852
pubmed: 33314700
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45
pubmed: 28572266
Biomolecules. 2020 Mar 19;10(3):
pubmed: 32204575
Genes Dev. 2012 Jun 15;26(12):1268-86
pubmed: 22713868
Int J Mol Sci. 2021 Jun 14;22(12):
pubmed: 34198491
Cancer Cell. 2006 Sep;10(3):191-202
pubmed: 16959611
J Clin Oncol. 2009 Sep 10;27(26):e108-9; author reply e110
pubmed: 19652052
Carcinogenesis. 2020 Dec 31;41(12):1635-1647
pubmed: 33159515
Lancet Oncol. 2021 Dec;22(12):1787-1798
pubmed: 34780712
Nat Commun. 2015 Mar 06;6:6302
pubmed: 25743702
Ann Intern Med. 1969 Oct;71(4):747-52
pubmed: 5360287
Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):
pubmed: 27815305
Nat Genet. 2018 Oct;50(10):1381-1387
pubmed: 30224644
Mol Carcinog. 2012 Oct;51 Suppl 1:E21-31
pubmed: 21976437
Membranes (Basel). 2022 Feb 09;12(2):
pubmed: 35207121
J Clin Oncol. 2015 Feb 20;33(6):602-9
pubmed: 25584008
Redox Biol. 2020 Jul;34:101517
pubmed: 32535544
JNCI Cancer Spectr. 2020 Jul 18;4(6):pkaa063
pubmed: 33490865
Nat Rev Cancer. 2014 May;14(5):359-70
pubmed: 24739573
J Steroid Biochem Mol Biol. 2019 Jun;190:250-255
pubmed: 30974190
EMBO Rep. 2017 Aug;18(8):1331-1351
pubmed: 28652379
J Exp Clin Cancer Res. 2019 Feb 4;38(1):53
pubmed: 30717802
RNA Biol. 2020 Nov;17(11):1648-1656
pubmed: 32432959
Front Genet. 2021 Sep 01;12:734809
pubmed: 34539758
Nat Commun. 2020 Aug 7;11(1):3945
pubmed: 32770028
Sci Adv. 2020 Jun 24;6(26):eaba3231
pubmed: 32637605
J Cell Biochem. 2016 Dec;117(12):2682-2692
pubmed: 27166782
J Med Genet. 2006 Jun;43(6):531-3
pubmed: 16258005
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11547-52
pubmed: 12972634
Oncogene. 2007 Apr 2;26(15):2212-9
pubmed: 17401430
Cancer. 2015 Jan 1;121(1):25-33
pubmed: 25186627

Auteurs

Valentina Rocca (V)

Department of Clinical and Experimental Medicine, Magna Græcia University of Catanzaro, 88100 Catanzaro, Italy.

Giovanni Blandino (G)

Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144 Rome, Italy.

Lucia D'Antona (L)

Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy.
Department of Health Sciences, Magna Græcia University of Catanzaro, 88100 Catanzaro, Italy.

Rodolfo Iuliano (R)

Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy.
Department of Health Sciences, Magna Græcia University of Catanzaro, 88100 Catanzaro, Italy.

Silvia Di Agostino (S)

Department of Health Sciences, Magna Græcia University of Catanzaro, 88100 Catanzaro, Italy.

Classifications MeSH